210 ILCS 83/5

in effect

(210 ILCS 83/5) (Section scheduled to be repealed on January 1, 2027) Sec. 5. MRSA control program. In order to improve the prevention of hospital-associated bloodstream infections due to methicillin-resistant Staphylococcus aureus ("MRSA"), every hospital shall establish an MRSA control program that requires: (1) Identification of all MRSA-colonized patients in all intensive care units, and other at-risk patients identified by the hospital, through active surveillance testing. (2) Isolation of identified MRSA-colonized or MRSA-infected patients in an appropriate manner. (3) Monitoring and strict enforcement of hand hygiene requirements. (4) Maintenance of records and reporting of cases under Section 10 of this Act. (Source: P.A. 95-312, eff. 8-20-07. Repealed by P.A. 104-508, eff. 1-1-27.)

Source: Open US Law by Vaquill AI (CC BY 4.0)URL: https://www.ilga.gov/legislation/ilcs/ilcs.aspFetched: 10/17/2026